PDCMED · Checked.be

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of PDCMED is 0.2% (very low). The 2024 annual accounts show equity of €65k and a net result of €29k. Its solvency ranks better than 45% of 6584 sector peers (fiscal year 2024). The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 2 annual accounts.

Signals

1 signal · with evidence

Consistently profitable

Positive net result in the two most recent financial years (2023 and 2024).

View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide

Deadline passed, not yet counted as missing

The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 17 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 04-07-2025, 27 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.

How we compute the deadline

The year end is derived from 2 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.

Deadline per financial year

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	04-07-2025	27 d early	2025-00228508
31-12-2023	31-07-2024	07-06-2024	54 d early	2024-00115066

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals

Young company

Founded in 2023, under 3 years, statistically higher risk.

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

0.2% Very low

0%0,5%1,5%4%10%≥25%

Lower-failure-rate sector −Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)

EBIT marginNot published (abbreviated filing)

Net result€29k-16.9%

Working capital€47k+29.2%

CSV export

Annual accounts & ratios

Source: NBB · 2024

Annual accounts filed on 04-07-2025 with the NBB · fiscal year 2024 · micro

Operating resultNet result

Sector comparison

Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (micro schema)

Metric	This company	Sector median	Position in the sector
Solvency	62.1%	66.7%	better than 45% of 6584 sector peers
Net result	€29k	€46k	better than 37% of 6578 sector peers
Equity	€65k	€79k	better than 44% of 6584 sector peers
Gross operating margin	€45k	€78k	better than 31% of 6586 sector peers
Total assets	€104k	€154k	better than 35% of 6587 sector peers

Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.

EBITDA

€45k

- 23-24

Net profit

€29k

-16.9% 23-24

Cash flow

€34k

- 23-24

Total assets

€104k

+77.3% 23-24

Equity

€65k

+79.2% 23-24

Working capital

€47k

+29.2% 23-24

Income taxes

€9k

-1.6% 23-24

Dividends

€859

+3.1% 23-24

Show 9 other metrics

Debt

€40k

+74.2% 23-24

Debt ≤ 1y

€39k

+73.5% 23-24

Current ratio

2.18

-15.7% 23-24

Quick ratio

2.18

-15.7% 23-24

Solvency

62.1%

+1.1% 23-24

Debt / equity

0.61

-2.8% 23-24

ROE

45.5%

-53.6% 23-24

ROA

28.3%

-53.1% 23-24

Interest coverage

23.93

- 23-24

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2024
Deposit	micro
Revenue	-
EBITDA	€45k
Net profit	€29k
Cash flow	€34k
Staff costs	-
Income taxes	€9k
Dividends	€859
Total assets	€104k
Equity	€65k
Debt	€40k
of which ≤ 1y	€39k
of which > 1y	-
Working capital	€47k
Employees (FTE)	-

Ratios (computed)

	2024
Current ratio	2.18
Quick ratio	2.18
Working capital ratio	44.7%
Solvency	62.1%
Debt / equity	0.61
Long-term debt ratio	-
Interest coverage	23.93
Gross margin	-
Net margin	-
ROA	28.3%
ROE	45.5%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Balance-sheet composition 2024

Assets

Fixed assets €18k · 17.5% Current assets €86k · 82.5%

Equity & liabilities

Equity €65k · 62.1% Debt €40k · 37.9%

Full annual accounts (20 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€104k
Fixed assets	21/28	€18k
Tangible fixed assets	22/27	€18k
Current assets	29/58	€86k
Amounts receivable within one year	40/41	€44k
Cash & bank	54/58	€36k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€104k
Equity	10/15	€65k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€63k
Amounts payable	17/49	€40k
Amounts payable within one year	42/48	€39k
Trade debts payable within one year	44	€812
Income statement
Gross operating margin	9900	€45k
Operating result	9901	€40k
Financial charges	65	€2k
Result before taxes	9903	€38k
Income taxes	67/77	€9k
Net result for the period	9904	€29k
Result to be appropriated	9905	€29k

This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →

Ratios computed by Checked.

Health barometer

FY 2024 · computed

93 / 100 Excellent

050100

Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →

Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.

Directors

Directors & mandates

1 director

2 of this company's 2 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing below: a director who resigned there may therefore still show here as sitting. See the acts under Publications.

Current directors & mandates

Justine Marie-Thérèse Narejos Eugenio
Director
State Gazette act 25070224 (03-06-2025)

Current
01-04-2025 → present

Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary	Activiteiten van medisch specialisten(86220)
Legal form	Private limited company(610)
Incorporation	09-10-2023
Status	Active
Postal code	4217

Structure & network

Locations & real estate

Registered office

on the map · from the address register

exact location from the address register On OpenStreetMap

Establishment units

1 location

PDCMED

Chaussée de Wavre 62, 4217 HéronActiviteiten van medisch specialisten

since 20232.350.770.947

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Parcels1

Ground area471 m²

Buildings1

Building footprint92 m²

Volume (LiDAR)790 m³

Tallest building9.8 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)